Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression.
Miras I, Gil A, Benavent M, Castilla MÁ, Vieites B, Dominguez-Cejudo MÁ, Molina-Pinelo S, Alfaro L, Frutos J, Ruiz-Borrego M, Falcón A, Cejuela M, Salvador-Bofill J.
Miras I, et al. Among authors: castilla ma.
Ther Adv Med Oncol. 2024 Dec 23;16:17588359241309169. doi: 10.1177/17588359241309169. eCollection 2024.
Ther Adv Med Oncol. 2024.
PMID: 39734711
Free PMC article.